New Key Statistics Module, Z-Score and F-Score
OTCPK:AQSZF Key Ratios
| Market Cap $ M | 2.92 |
| Enterprise Value $ M | 6.91 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 15.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -9.56 |
| 10-y EBITDA Growth Rate % | 22.70 |
| 5-y EBITDA Growth Rate % | 7.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.60 |
| EV-to-EBITDA | -4.84 |
| PEG | -- |
| Shares Outstanding M | 132.63 |
| Net Margin (%) | -1,864.96 |
| Operating Margin % | -1,750.43 |
| Pre-tax Margin (%) | -1,864.96 |
| Quick Ratio | 0.07 |
| Current Ratio | 0.09 |
| ROA % (ttm) | -195.40 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -40.89 |
| Dividend Yield % | -- |
| Altman Z-Score | -56.02 |
AQSZF Number of Guru Trades
AQSZF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AQSZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AQSZF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aequus Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:AQSZF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers